Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,505 | -1,815 | -17,084 | -48,955 | -29,352 |
| Depreciation Amortization | N/A | N/A | 175 | 377 | 307 |
| Accounts payable and accrued liabilities | 232 | 124 | -490 | 1,260 | 2,367 |
| Other Working Capital | 382 | 247 | -2,915 | 6,078 | 383 |
| Other Operating Activity | -227 | -121 | 2,632 | 6,771 | 3,769 |
| Operating Cash Flow | $-2,118 | $-1,565 | $-17,682 | $-34,469 | $-22,526 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 6,230 | -2,222 | -3,450 |
| PPE Investments | -73 | N/A | -133 | -1,968 | -1,496 |
| Investing Cash Flow | $-73 | $N/A | $6,097 | $-4,190 | $-4,946 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 26,325 | 26,325 |
| Debt Repayment | N/A | N/A | N/A | -3,000 | -3,000 |
| Common Stock Issued | N/A | N/A | 1,770 | 28,861 | 327 |
| Other Financing Activity | 4,856 | 4,856 | 0 | -8,647 | -8,631 |
| Financing Cash Flow | $4,856 | $4,856 | $1,770 | $43,539 | $15,021 |
| Beginning Cash Position | 5,016 | 5,016 | 40,813 | 35,933 | 35,933 |
| End Cash Position | 7,681 | 8,307 | 30,998 | 40,813 | 23,482 |
| Net Cash Flow | $2,665 | $3,291 | $-9,815 | $4,880 | $-12,451 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,118 | -1,565 | -17,682 | -34,469 | -22,526 |
| Capital Expenditure | -73 | N/A | -133 | -1,968 | -1,496 |
| Free Cash Flow | -2,191 | -1,565 | -17,815 | -36,437 | -24,022 |